SGAM
COCH icon

Seaport Global Asset Management’s Envoy Medical COCH Stock Holding History

Seaport Global Asset Management’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$67K Buy
7,000
+1,000
+17% +$9.68K 0.17% 52
2021
Q2 		$58K Buy
+6,000
New +$58.3K 0.11% 43

Other funds holding COCH

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Seaport Global Asset Management's COCH Position: Q3 2021 in Review

Seaport Global Asset Management increased its Envoy Medical (COCH) stake by 17% in Q3 2021, buying an estimated $9.68K and bringing the position to 7,000 shares worth $67K. The position accounts for 0.17% of the portfolio, ranked #52.

Seaport Global Asset Management first reported a position in COCH in Q2 2021 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold COCH as of Q3 2021.

  • Seaport Global Asset Management held 7,000 shares of Envoy Medical worth $67K as of Q3 2021.
  • Seaport Global Asset Management bought 1,000 Envoy Medical shares in Q3 2021, an estimated $9.68K.
  • Envoy Medical made up 0.17% of Seaport Global Asset Management's portfolio in Q3 2021, its #52 holding.
  • Seaport Global Asset Management first reported a position in Envoy Medical in Q2 2021 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2021.

Based on Seaport Global Asset Management's 13F filing for Q3 2021, filed 22 Nov 2021.